With over two decades of experience in ophthalmology, Dr. Kaiser has dedicated his career to advancing the diagnosis, treatment, and research of complex retinal disorders such as age-related macular degeneration (AMD), retinitis pigmentosa, and diabetic retinopathy. He is a leading authority in the use of cutting-edge imaging technologies and novel therapeutic approaches, including gene therapy and advanced pharmacologic interventions.

Dr. Kaiser has contributed extensively to clinical research, authoring numerous peer-reviewed publications that have shaped current understanding and management of degenerative retinal conditions. He is actively involved in multiple clinical trials, striving to develop innovative treatments that improve patient outcomes and preserve vision.

His compassionate patient care, combined with his commitment to scientific advancement, positions Dr. Peter Kaiser as a foremost expert dedicated to combating vision loss caused by degenerative retinal diseases.